Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-12-18
pubmed:abstractText
EPO (eosinophil peroxidase) and MPO (myeloperoxidase) are highly basic haem enzymes that can catalyse the production of HOBr (hypobromous acid). They are released extracellularly by activated leucocytes and their binding to the polyanionic glycosa-minoglycan components of extracellular matrix (proteoglycans and hyaluronan) may localize the production of HOBr to these materials. It is shown in the present paper that the reaction of HOBr with glycosaminoglycans (heparan sulfate, heparin, chondroitin sulfate and hyaluronan) generates polymer-derived N-bromo derivatives (bromamines, dibromamines, N-bromosulfon-amides and bromamides). Decomposition of these species, which can occur spontaneously and/or via one-electron reduction by low-valent transition metal ions (Cu+ and Fe2+), results in polymer fragmentation and modification. One-electron reduction of the N-bromo derivatives generates radicals that have been detected by EPR spin trapping. The species detected are consistent with metal ion-dependent polymer fragmentation and modification being initiated by the formation of nitrogen-centred (aminyl, N-bromoaminyl, sulfonamidyl and amidyl) radicals. Previous studies have shown that the reaction of HOBr with proteins generates N-bromo derivatives and results in fragmentation of the polypeptide backbone. The reaction of HOBr with extracellular matrix synthesized by smooth muscle cells in vitro induces the release of carbohydrate and protein components in a time-dependent manner, which is consistent with fragmentation of these materials via the formation of N-bromo derivatives. The degradation of extracellular matrix glycosaminoglycans and proteins by HOBr may contribute to tissue damage associated with inflammatory diseases such as asthma.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-10994876, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-11096071, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-11485572, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-12208372, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-12374790, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-12885584, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-12911330, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-14599211, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-14633118, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-15001454, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-15096049, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-15790935, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-15872080, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-15932347, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16064139, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16125131, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16140210, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16300375, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16506790, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-16632123, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-2425661, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-2826304, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-3033023, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-6433889, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-7852368, http://linkedlifedata.com/resource/pubmed/commentcorrection/17014424-8395774
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1470-8728
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
401
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
587-96
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Degradation of extracellular matrix and its components by hypobromous acid.
pubmed:affiliation
The Heart Research Institute, 114 Pyrmont Bridge Road, Sydney, NSW 2050, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't